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Background: Proteinuria and dilatation of the urinary tract are both relatively common in pregnancy, the latter
with a spectrum of symptoms, from none to severe pain and infection. Proteinuria is a rare occurrence in acute
obstructive nephropathy; it has been reported in pregnancy, where it may pose a challenging differential diagnosis
with pre-eclampsia.
The aim of the present study is to report on the incidence of proteinuria (≥0.3; ≥0.5 g/day) in association with
symptomatic-severe urinary tract dilatation in pregnancy.
Methods: Case series. Setting: Nephrological-Obstetric Unit dedicated to pregnancy and kidney diseases (January
2000-April 2011). Source: database prospectively updated since the start of the Unit. Retrospective review of clinical
charts identified as relevant on the database, by a nephrologist and an obstetrician.
Results: From January 2000 to April 2011, 262 pregnancies were referred. Urinary tract dilatation with or without
infection was the main cause of referral in 26 cases (predominantly monolateral in 19 cases): 23 singletons, 1 lost to
follow-up, 1 twin and 1 triplet. Patients were referred for urinary tract infection (15 cases) and/or renal pain (10
cases); 6 patients were treated by urologic interventions (“JJ” stenting). Among them, 11 singletons and 1 triple
pregnancy developed proteinuria ≥0.3 g/day (46.1%). Proteinuria was ≥0.5 g/day in 6 singletons (23.1%). Proteinuria
resolved after delivery in all cases. No patient developed hypertension; in none was an alternative cause of
proteinuria evident. No significant demographic difference was observed in patients with renal dilatation who
developed proteinuria versus those who did not. An association with the presence of “JJ” stenting was present
(5/6 cases with proteinuria ≥0.5 g/day), which may reflect both severer obstruction and a role for vescico-ureteral
reflux, induced by the stent.
Conclusions: Symptomatic urinary tract dilatation may be associated with proteinuria in pregnancy. This
association should be kept in mind in the differential diagnosis with other causes of proteinuria in pregnancy,
including pre-eclampsia.Background
Dilatation of the urinary tract is common in pregnancy
in particular in the last trimester [1-4]. The cause of the
dilatation is disputed, some advocating hormonal effects
and others obstruction. There is a broad spectrum of
this ‘syndrome’, some women may be completely asymp-
tomatic, others have only transient mild loin pain while* Correspondence: gbpiccoli@yahoo.it
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reproduction in any medium, provided the orother patients experience recurrent episodes of severe
loin pain and/or lower abdominal pain; very occasionally
these anatomical changes can be exaggerated with
massive ureteral and renal pelvis distension (as well as
slight reduction in renal cortical width) and very rarely,
the changes may be extreme and precipitate a so-called
“over-distension syndrome” even with reversible acute
renal failure [5-7].
In general, dilatation on the right side is more com-
mon and more pronounced, being reported, in a mild
form, usually involving calices only, in up to 90% of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mild urinary dilatation tends to become bilateral, in
keeping with the theory that it is caused by compression
by the iliac arteries where the latter cross the true bony
pelvis [8].
On the right side, dilatation is usually considered as
presumably related to pregnancy, while dilatation on
the left side, especially if unilateral, is probably related
to a different situation and is less likely to resolve after
delivery [5-8].
The possibility that urinary tract obstruction may oc-
casionally cause proteinuria outside of pregnancy is well
known, even if not frequently reported [9-11]; its degree
is usually sub-nephrotic and its pathogenesis is usually
related to increased pressure in the renal pelvis, leading
to a diuretic response from the contralateral kidney.
Proteinuria caused by kidney obstruction is usually mild
and considered of tubular origin, although different
mechanisms may be operating [12,13]. Very few cases of
massive proteinuria in the context of unilateral renal
dilatation have been reported. Notably, a relatively re-
cent report dealt with a pregnant patient who developed
nephrotic proteinuria. In this very well documented case,
proteinuria was found to stem from both kidneys at the
time of laparoscopic intervention and resolved after
pyeloplasty performed a few months after delivery [14].
The authors of the report stated that the lack of protein-
uria prior to pregnancy and the failure to resolve after
delivery pointed to pregnancy as a catalyst in the devel-
opment of proteinuria [14]. A few interesting cases had
been reported, in which urinary tract dilatation was pre-
sumably the cause of severe pre-eclampsia or of kidney
function impairment [15,16]. However, according to a
Medline search at June 2011 (combining the terms pro-
teinuria, hydronephrosis, kidney and dilatation with
pregnancy), we could locate no surveys of the of the
prevalence of proteinuria associated with urinary tract
dilatation in pregnancy in the last decade, with the ex-
ception of the case mentioned above.
This issue is however of great interest, particularly with
respect to the differential diagnosis with pre-eclampsia
and other causes of pregnancy-induced proteinuria, in-
cluding a vast array of chronic kidney diseases.
We therefore evaluated whether or not proteinuria
without obvious cause was present in 26 pregnant women,
referred to our specialty clinic with excessive and/or
symptomatic urinary tract dilatation in pregnancy, with or
without sign of upper urinary tract infection.
Methods
Study setting
The study was performed in the Maternal-Foetal Unit of
the University Hospital OIRM S. Anna, Turin, Italy,
where all pregnant patients with kidney diseases havebeen followed by the same obstetric and nephrological
team since 2000. A large database had been structured
and data were prospectively gathered since the start of
the activity [17].
From January 2000 to April 30th 2011, 262 pregnancies
were observed in 235 women referred to our Unit dedi-
cated to pregnancy and kidney diseases. Twenty-six of
the patients (26 patients; 26 pregnancies) displayed ex-
cessive (above 3 cm) and/or symptomatic urinary tract
dilatation (10% of the overall referred population) as a
main clinical problem and reason for referral. The
present analysis is focused on this cohort.Diagnostic and follow-up policies. Main definitions
The diagnostic work-up for patients with signs or symp-
toms of kidney disease referred to the Unit includes
renal function assessment (at the first visit in the Unit:
creatinine and proteinuria on 24-hour urine collection)
and immunological and coagulation screening. Abdom-
inal ultrasounds are performed at least once in all cases;
they are routinely performed in the same two settings
(Materno-Foetal Hospital and S Luigi Hospital) by a
small group of skilled operators.
In the case of known urological problems preceding
pregnancy, the follow-up policy includes urinalysis and
urinary cultures every week, or on alternate weeks, as
well as ultrasounds at least every three months, and
more frequently in the case of urinary tract dilatation.
Since the entity of the urinary tract dilatation is also
dependent upon hydration and position, a clear cut-off
between physiological and pathological was not available
from the literature; for the present study, we considered
as “excessive” the urinary tract dilatation when exceed-
ing 3 cm of maximal diameter, or over 2 cm when symp-
tomatic [1,6-8,18,19]. The dilatation was considered as
symptomatic when accompanied by flank pain, enhanced
by palpation, and or by signs of upper urinary tract
infection.
Due to the risks of any invasive manoeuvre in preg-
nancy, positioning of “JJ stents” is limited to cases with
severe dilatation, untreatable pain and/or evidence of
complete or almost complete obstruction and infection.
Hypertension is defined as systolic blood pressure ≥140
and/or diastolic blood pressure ≥90, or anti-hypertensive
therapy. In the case of hypertension, 24-hour blood
pressure monitoring and echocardiography are per-
formed; other analyses are prescribed on demand. CKD is
classified according to K-DOQI guidelines, using pre-
pregnancy data whenever possible. When these are not
available, data at referral are used. The Cockcroft-Gault
and EPI formulae (based upon the first available serum
creatinine data) and 24-hour urine assessments (for the
subsequent measurements) are routinely employed for the
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tions, please refer to our previous study [17].
The frequency of nephrological and obstetric controls
is individualized, weekly to monthly. In addition to
the routine pregnancy controls, creatinine clearance on
24 hour urine collection is routinely required at referral;
all patients undergo (at least) a monthly determination
of serum creatinine and dipstick proteinuria, uric acid,
urinalysis and urinary culture, serum electrolytes, coagu-
lation and blood cell counts. If proteinuria is present,
24-hour urine collection is requested. Other tests are re-
quired on demand. Proteinuria is classified into tubular
pattern (exclusive or prevalent: Beta 2 microglobulin,
alfa 2 microglobulin, lysozime), glomerular pattern (ex-
clusive or prevalent: albumin, transferrin, IgG), and
mixed pattern.
Ultrasound biometry and Doppler velocimetry of uter-
ine and umbilical arteries are individualized (every two-
four weeks if there is a risk of foetal growth restriction).
Hospitalization is required in the presence of uncon-
trolled or new-onset hypertension, worsening of renal
function, new onset or worsening of proteinuria, or any
intercurrent problem of mother and/or foetus (abnor-
mal foetal growth and/or severely abnormal umbilical
Doppler) [17].
Preterm delivery is defined as delivery before 37 com-
pleted weeks of gestation; “early pre-term” delivery is de-
fined as delivery before the 34th completed gestational
week. Caesarean section is performed for foetal indica-
tions or in cases of unfavourable conditions for, or lack
of response to, induction. Apgar scores are recorded at 1
and 5 min by the neonatologists. A newborn is defined
as Small for Gestational Age (SGA) when the birth
weight is below the 10th centile according to Italian birth
weight references [17].
Patient selection
The patients were selected from the Unit’s database
according to the following criteria: symptomatic or se-
vere urinary tract dilatation at ultrasounds performed at
any time during pregnancy; availability of at least one
full functional evaluation with 24-hour proteinuria. In all
cases, at least 2 controls of 24-hour proteinuria were
available. Patients referred for acute upper urinary tract
infection who did not display renal dilatation at ultra-
sounds were selected as a control group (14 cases, from
the 262 pregnancies referred). After the initial selection,
the clinical charts of all patients were reviewed by the
same operators.
As the definition of “significant” proteinuria may be
controversial, and some Authors stress the potential
overlap between normal and pathological data, setting
the limit at 0.3 g/day, two cut-points were tested: 0.3
and 0.5 g/day. In the patients who had developedproteinuria >=0.5 g/day, post-pregnancy data were
obtained from the clinical charts or by phone inquiry.
Ethical approval and consent to the study
The overall research and build-up of the archives of the
patients followed in our Unit, focused on the differential
diagnosis between pre-eclampsia and CKD and on the
risks of CKD in pregnancy was approved by the Ethical
committee of the OIRM-S. Anna Hospital of the Univer-
sity of Turin (number 335; protocol 11551/c28.2; data of
final approval 4.3.2011); since the start of the activity, all
patients followed in the Unit signed an informed con-
sent for the use of anonymous data for research pur-
poses. Specific consent was requested to the patient
whose image is reported in the present paper.
Statistical analysis
A descriptive analysis was performed as appropriate.
The patients with renal dilatation and proteinuria
were compared with the cases without proteinuria by
Chi square test (discrete variables) and Student’s t-test
(continuous variables). For non parametric comparisons,
Mann Whitney test was employed.
Results
Prevalence of proteinuria in pregnant patients with
urinary tract dilatation
In the study period (January 2000 - April 2011), 262
pregnancies in 235 women were referred to the
Outpatient Unit for Kidney Diseases in Pregnancy.
Symptomatic or excessive urinary tract dilatation was
the main sign in 26 cases (10% of pregnancies): 23 sin-
gletons, 1 lost to follow-up, one twin, one triple preg-
nancy. Dilatation was predominantly monolateral in 19
cases.
The overall prevalence of proteinuria ≥0.3 g/day (the
threshold level for the differential diagnosis with pre-
eclampsia) associated with urinary tract dilatation was
high: 11 singletons and 1 triple pregnancy developed
proteinuria before term (46.1% of the overall population;
48% of the singletons, not considering the patient lost to
follow-up).
Proteinuria was ≥0.5 g/day in 7 cases, namely 6 single-
tons and one triple pregnancy (26.9%).
Patients were mainly referred for upper urinary tract
infection (15 cases) and/or renal pain (10 cases). In 4
cases, the finding of urinary tract dilatation exceeding
3 cm was incidental during an evaluation of kidney
ultrasounds.
Six patients (5 of them in the higher proteinuria
group) were treated by urologic interventions (“JJ”
stenting), 4 in our institution and 2 in a different setting,
before referral to our Unit.
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proteinuria
The main clinical and biochemical data of the patients
with and without proteinuria (cutpoint at ≥0.3 g/day
and ≥0.5 g/day) associated with urinary tract dilatation
are reported in Table 1.
Due to the lack of referral data as for incidence of
low-grade proteinuria in multiple pregnancies, only sin-
gletons are reported. One patient dropped out fromTable 1 Prevalence and main characteristics of patients, acco
infection (data at referral and delivery)
Patients with urinary tract
dilatation and proteinuria
<0.3 g/day (12 pts)
Patients with urina
dilatation and pro
≥0.3 <0.5 g/day (5
Mean age (start of
pregnancy) ± sd
28.6 ± 5.93 29.2 ± 5.93
Primiparous n (%) 5 (41.7%) 3 (60%)
Median week of
referral




0.6 ± 0.12 0.7 ± 0.09











0.6 ± 0.15 0.6 ± 0.20




0.1 (0.07-0.16) 0.3 (0.3-0.38)
Mean gestational
age ± sd ***
38.8 ± 1.7 38.6 ± 1.8
Preterm delivery




10 (83.3%) 2 (40%)
Weight of newborn
± sd ****




Note: Singletons only; one twin and one triplet pregnancies in the group with dilat
before delivery (also excluded).
All patients underwent at least two measurements of proteinuria on 24 hour urine
* Mann–Whitney test: group 3 versus 1: p= 0.002; versus 2: p=0.019; versus 4 p=0.0
** Mann–Whitney test: group 3 versus 1: p= 0.000; versus 2: p=0.005; versus 4 p=0.
*** T student test: group 3 versus 1: p= 0.0016; versus 2: p=0.0184; versus 4 p=0.00
**** T student test: group 3 versus 1: p= 0.0077; versus 2: p=0.0437; versus 4 p=0.0
§ Chi square test: group 3 versus 1: p= 0.0016; versus 2: p=0.1356; versus 4 p=0.000
§§ Chi square test: group 3 versus 1: p= 0.1160; versus 2: p=0.0971; versus 4 p=0.00
Singletons only.follow-up before delivery, and was likewise excluded,
thus leaving 23 cases for the statistical analysis.
No significant baseline difference was observed in pa-
tients with renal dilatation who developed proteinuria
versus those who did not, nor in the cohort of patients
referred for upper urinary tract infection without pro-
teinuria (Table 1). Proteinuria always resolved after de-
livery and after stent removal, routinely performed




Patients with urinary tract
dilatation and proteinuria
≥0.5 g/day (6 pts)
Patients with acute urinary
tract infection without
dilatation (14 pts)
29.8 ± 4.49 29.8 ± 6.60
2 (33.3%) 9 (64.3%)
30 (18–35) 21 (7–36)
of pregnancy
0.6 ± 0.21 0.6 ± 0.13
125 ± 25 120 ± 14
No No
1.09 (0.1-2.65) 0.1 (0.06-0.53)
5/6 0
elivery
0.7 ± 0.22 0.6 ± 0.12
118 ± 27 117 ± 14
No 1 (7.1%)
1.7 (0.6-2.54) 0.1 (0.1-0.23)
35.5 ± 1.8 38.8 ± 1.4
4 (66.7%) 0
6 (100%) 12 (85.7%)
2553.3 ± 372.86 3236.7 ± 494.7
1 (16.7%) 1 (7.1%)
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tient developed hypertension during pregnancy or in the
first month after delivery; no alternative cause of pro-
teinuria was evident. In keeping with the absence of
other pathological conditions, delivery was vaginal in the
vast majority of the cases in all subsets considered
(against a background of 25% caesarean deliveries in
low-risk pregnancies in our Unit [17]).
With regard to outcomes, patients with higher levels
of proteinuria displayed significantly greater morbidity
than those without proteinuria: delivery was preterm in
4/6 cases and thus a significantly lower birth weight was
recorded (Table 1).
Interestingly, there was a strong association with the
positioning of JJ stenting and proteinuria, as stentingTable 2 Main reasons for referral and main clinical characteri
dilatation
Case 1 Case 2 Ca




BMI (start of pregnancy)
Kg/m2
22.5 21.1 2
Parity 1011+1 1001 0




Stone disease (active) Yes Yes
Stone disease (previous) No Yes






Side of dilatation Right (stenting);













2.5 g/day 3.5 g/day 2.5
Data at d
Gestational age 32+4 36 US
Weight gain - Kg 14 10
Type of delivery vaginal Vaginal va
Children: Case 1 Case 2 Ca
Sex M M
Weight 2400 2450 2
Centile 70th 15th 1
Apgar 50 9/9 9/9 9
Note: **the patient was relatively de-hydrated at the first assessment; a second me
US adjusted: gestational age assessed with US datation.had been performed in 5 cases with excessive renal dila-
tation and proteinuria and in only one case in the low-
proteinuria group (Table 1).
Characteristics of patients with proteinuria ≥0.5 g/day
The main clinical features and outcomes of singletons
with proteinuria equal or above 0.5 g/day are summarised
in Table 2. Only one patient (case 2) had a history of stone
disease, although previously undetected kidney stones
were found at ultrasounds in 3/5 cases. One patient had a
history of urinary tract involvement, with colicky pain dur-
ing a previous pregnancy. All patients had normal renal
function throughout pregnancy and no ultrasound evi-
dence of any condition predisposing to proteinuria or
otherwise indicating “chronic kidney disease” (such asstics in singletons with ≥0.5 g/proteinuria/day and renal
se 3 Case 4 Case 5 Case 6
27 27 30 36
64 55 65 50
3.5 21.5 26 18.4
000 1001 1001 0000
5+2 32+4 35+4 26+6
.95 0.36 0.45 0.55
No Yes (brushite) No No
No No No No
No Yes Yes No
No No No No
ight Left Right Right
cm 3.5 cm 2** cm 6.5 cm






g/day 1.2 g/day 2.7 g/day 0.8 g/day
elivery
38 36+1 37+2 31+4
15 8 13 9
ginal vaginal vaginal vaginal
se 3 Case 4 Case 5 Case 6
M F M F
760 2600 3110 2000
0th 30th 50th 60th
/9 9/9 9/9 8/9
asurement after a few days of i.v. fluids and antibiotic therapy exceeded 3 cm.
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chyma); no patient had signs or history compatible with
vescico-ureteral reflux. No patient had evidence of viral
infection (hepatitis B, C and HIV were negative in all
cases), and all had normal “basic” immunological testing
(complement, antinuclear factors, ENA, ANA, immuno-
globulin levels). Proteinuria typing was performed in three
patients; it revealed a mixed glomerular and tubular pat-
tern with non-selective glomerular component in all three
patients.
In pregnancy, proteinuria was not limited to the phase
of active infection in any patient, as it persisted or even
developed (cases 4-5-6) after resolution of the acute in-
fectious phase. Five patients underwent ureteral stenting,
in 3 because of upper urinary tract infection and active
stone disease, and in 2 because of severe infection and
pain unresponsive to the conventional pain relievers
(Table 2). Interestingly, the residual dilatation of the urin-
ary tract was not correlated with the degree of proteinuria,
which persisted even after obstruction was at least par-
tially relieved by renal stenting (Figure 1, case 5). In no
case proteinuria decreased after stenting, and in three pa-
tients it increased.
Stenting was a cause of significant morbidity in two
cases: case 5 (urinary pain, urgency and frequency) andFigure 1 Kidney ultrasounds in case 5, after the positioning of JJ sten
after “JJ stenting”, reducing the dilatation, and in the absence of infection.
proteinuria was absent at the control one month after delivery.case 6, in which the invasive manoeuvre could have
played a role in the preterm delivery (Table 2).
There was no evidence of an effect of the urological
problem, the eventual infection or the therapies on the
growth curves. In fact, the newborn was small for gesta-
tional age in only two cases, one in the subset with
higher proteinuria and one in the control group with
upper urinary tract infections without dilatation.
The urinary picture normalized in all patients within
three months after delivery, with the disappearance of
proteinuria; the ureteral stent was safely removed in all
cases; it is impossible to disentangle the effect of ureteral
stent removal from the effect of delivery, as the patients
perform a limited number of 24 hour urine collections
after delivery (usually 1 at 1 month, and - if proteinuria
over 0.3 g/day is still present and decreasing - the test is
repeated at 3 months).
Discussion
The present report deals with an interesting associ-
ation, not extensively studied thus far and possibly
underreported, between symptomatic and/or excessive
urinary tract dilatation and proteinuria in pregnancy.
Indeed, our extensive Medline search revealed only one
recently published case of an association betweent. Only minimal dilatation is present; however, proteinuria persisted
“JJ” was removed one week after delivery (proteinuria 0.5 g/day);
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nancy in the last decade; a few other cases in which a
pre-eclamptic syndrome was probably triggered by
dilatation had been previously reported [13,15,20-22].
Our cases were less extensively studied than the one
reported by Afzali and co-workers, also because protein-
uria decreased below 0.3 g/day shortly after pregnancy
in all, thus limiting the diagnostic potential which is
higher after delivery [13]. Interestingly, in both our small
series and the recently reported case, renal function was
normal and no history of kidney disease (with particular
reference to reflux nephropathy) was available nor was a
different cause of kidney disease suggested by the ul-
trasound patterns. This differentiates our cases from
reports of the risks of pregnancy in women with vescico-
ureteral reflux in infancy, a potential risk factor even in
the presence of normal kidney function [20-23].
It is well known that proteinuria may develop late in
urological disease. This is usually considered to be
caused by nephron loss and a poor prognostic sign, oc-
curring in late stages of the disease when significant re-
duction of the kidney parenchyma is usually evident at
ultrasounds [19,24,25]. However, neither our patients
nor the case reported by Afzali displayed such a picture
and the kidney function was normal in all cases. A “renal
reflex” has been postulated in experimental animals and
in humans, and was called into question in the case re-
port by Afzali and co-workers [13,26,27].
It is very difficult to suggest a univocal interpretation
of the observed data.
First of all, our cases were symptomatic or displayed
excessive dilatation (over 3 cm); this referral pattern dif-
ferentiates our observations from those of other studies,
in which mild or minimal dilatations are reported, in the
assessment of the frequency of urinary tract dilatation in
pregnancy [24,25]. Thus, our series may be considered
as negatively selected, as small symptomless dilatations
are neither identified nor referred (the use of maternal
kidney ultrasounds in pregnancy is very limited in the
clinical practice). Furthermore, in the presence of pro-
teinuria, ultrasounds are not routinely performed in
all settings, and a relationship between the so-called
pregnancy-induced proteinuria and non symptomatic
urinary tract dilatation may escape diagnosis.
Therefore, we will limit our report to the description of
an association that might be more frequent than previ-
ously reported, possibly because of a trigger effect of preg-
nancy on the development of proteinuria in the context of
various kidney diseases, including symptomatic or severe
urinary tract dilatation. As urinary picture normalized in
all patients after delivery and ureteral stent removal; it was
impossible to disentangle the effect of each ones. However,
the clinical relevance in the differential diagnosis with pre-
eclampsia is unaffected by the cause of proteinuria.A role for the increase in abdominal pressure may be
postulated, together with a facilitating role of the urinary
tract infections, where present. However, possibly to the
negative selection of the cases, mentioned above, a
clear-cut relationship was not identified.
Pregnancy may facilitate the development of proteinuria
in the context of severe-symptomatic urinary tract dilata-
tion via the changes in the metabolic milieu, through
hyperfiltration or both, thus suggesting to further investi-
gate in these fields. One possible explanation is that pro-
teinuria increases steadily in pregnant women as the levels
of the soluble fms-like tyrosine kinase-1(sFlt-1) rise, whose
effect on podocytes is to increase proteinuria. Patients
with chronic interstitial nephritis might have reached the
tubular maximum of reabsorbtion and display proteinuria
near term, when circulating sFlt-1 is at its highest [28,29].
The striking association with ureteral stenting in our
series needs further confirmation on a larger scale; in-
deed, there is a strong selection bias, as only the most
symptomatic cases usually undergo invasive procedures.
A role of iatrogenic vescico-ureteral reflux (linked to the
presence of a ureteral stent) in the persistence of tubular
damage (and/or of the inflammatory changes associated
with urinary reflux and infection) can be postulated, but
once again this awaits further confirmation in a pro-
spective larger-scale analysis.
Our study has several limitations, partly shared by
other observational studies in pregnancy: the problem of
low grade proteinuria is very important in particular in a
situation in which the upper physiological limits “touch”
the limit for the definition of a severe disease (pre-
eclampsia). Hence, we may have missed some cases with
low-grade proteinuria and urinary tract dilatation, who
tested negative at conventional urinalysis; conversely, the
cases who tested positive at urinalysis or who were diag-
nosed with proteinuria at 24 hour urine collections were
repeatedly controlled, thus ensuring against false posi-
tives (Tables 1, 2).
The interest in our report is mainly clinical, since it
raises the hypothesis of an alternative source of protein-
uria in a context in which pre-eclampsia is the most
likely diagnosis. The clinical management would be dif-
ferent, for example the controversial “fluid management”
often employed to offset the pre-eclamptic response
may even be harmful in the context of urinary tract
dilatation.
The treatment of the pregnant patient presenting with
upper urinary pain and fever, or a kidney stone is quite
obvious, but the differential diagnosis may be difficult in
the absence of these symptoms. Hence, our case series
suggests that an obstructive origin should be considered
in the differential diagnosis of proteinuria in pregnancy,
particularly in cases presenting without hypertension
and with normal renal function. Further research in this
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logical teams, is recommended.
Conclusions
This report suggests considering urinary tract dilatation
in the differential diagnosis of the new onset of protein-
uria in pregnancy and, vice versa, systematically testing
for proteinuria in pregnant patients with severe and
symptomatic urinary tract dilatation. Our series also
suggests a possible association between “JJ stenting” and
the development of proteinuria, even though the associ-
ation may be due to the negative selection of cases need-
ing urological interventions.
This diagnosis could be very important in the differen-
tial diagnosis with other pregnancy-related conditions,
such as pre-eclampsia. Greater awareness of this issue
may help clarify the mechanisms underlying the devel-
opment of proteinuria in the context of obstructive kid-
ney diseases.
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